Online citations, reference lists, and bibliographies.
← Back to Search

Relationships Among Bleeding Severity, Health‐related Quality Of Life, And Platelet Count In Children With Immune Thrombocytopenic Purpura

C. Neunert, G. Buchanan, V. Blanchette, D. Barnard, N. Young, C. Curtis, R. Klaassen
Published 2009 · Medicine

Save to my Library
Download PDF
Analyze on Scholarcy Visualize in Litmaps
Share
Reduce the time it takes to create your bibliography by a factor of 10 by using the world’s favourite reference manager
Time to take this seriously.
Get Citationsy
Important outcomes for children with immune thrombocytopenic purpura (ITP) include health‐related quality of life (HRQOL) and bleeding severity. A HRQOL instrument for children with ITP, the Kids' ITP Tools (KIT), was recently validated. Secondary analysis of the KIT database was performed to determine relationships among platelet count, bleeding severity and HRQOL. Bleeding severity grade correlated with platelet count in chronic ITP but not in acute ITP. Platelet count and bleeding severity failed to have any statistically significant correlations with the KIT scores. These findings suggest that relationships among outcome measures in children with ITP, using currently available instruments, remain poorly defined. Pediatr Blood Cancer 2009;53:652–654. © 2009 Wiley‐Liss, Inc.
This paper references



This paper is referenced by
10.21037/AOB-20-96
Pediatric immune thrombocytopenia (ITP) treatment
T. Kim (2021)
10.1007/s00277-021-04590-0
Romiplostim in children with newly diagnosed or persistent primary immune thrombocytopenia
J. Grainger (2021)
10.1002/pbc.29023
Quality of life is an important indication for second‐line treatment in children with immune thrombocytopenia
Kristin A Shimano (2021)
10.1136/bmjopen-2020-044885
Phase 3 randomised trial of eltrombopag versus standard first-line pharmacological management for newly diagnosed immune thrombocytopaenia (ITP) in children: study protocol
Kristin A Shimano (2021)
10.1182/bloodadvances.2019001343
IVMP+IVIG raises platelet counts faster than IVIG alone: results of a randomized, blinded trial in childhood ITP.
M. Carcao (2020)
10.1007/s11239-020-02036-4
Silent bleeding in children and adolescents with immune thrombocytopenia: relation to laboratory parameters and health related quality of life
A. Tantawy (2020)
10.1016/j.clinthera.2020.02.020
The Cost-Effectiveness of Eltrombopag for the Treatment of Immune Thrombocytopenia in the United States.
G. Tremblay (2020)
10.1186/s12955-020-01572-0
Measuring parent proxy-reported quality of life of 11 rare diseases in children in Zhejiang, China
Qisheng Gao (2020)
10.1111/bjh.16387
Fatigue, executive function and psychological effects in children with immune thrombocytopenia: a cross‐sectional study
S. Towner (2020)
10.3389/fped.2019.00163
A Narrative Approach to Describe QoL in Children With Chronic ITP
P. Giordano (2019)
10.1002/ajh.25409
Association of a positive direct antiglobulin test with chronic immune thrombocytopenia and use of second line therapies in children: A multi‐institutional review
T. Kim (2019)
10.1182/bloodadvances.2019000966
American Society of Hematology 2019 guidelines for immune thrombocytopenia.
C. Neunert (2019)
10.1055/s-0039-1683416
Epidemiology and Clinical Manifestations of Immune Thrombocytopenia.
R. Kohli (2019)
10.2147/PROM.S140932
Immune thrombocytopenia: improving quality of life and patient outcomes
P. Trotter (2018)
10.1007/978-3-319-68038-5_15
Health-Related Quality of Life in Patients with Immune Thrombocytopenia
R. Klaassen (2018)
10.1002/pbc.26736
Predictors of remission in children with newly diagnosed immune thrombocytopenia: Data from the Intercontinental Cooperative ITP Study Group Registry II participants
C. Bennett (2018)
10.1007/s12288-018-1031-0
Psychiatric Disorders and Quality of Life in Egyptian Patients with Chronic Immune Thrombocytopenic Purpura: A Single Center Study
S. Yahia (2018)
10.1002/pbc.26405
Patterns and influences in health‐related quality of life in children with immune thrombocytopenia: A study from the Dallas ITP Cohort
A. Flores (2017)
10.1097/01.NPR.0000484317.83554.24
When and how to treat childhood immune thrombocytopenia.
Jennifer Allen (2016)
I When and how to treat childhood immune
(2016)
10.1186/s12955-016-0445-3
Health-related quality of life in children with chronic immune thrombocytopenia in China
Heng Zhang (2016)
10.1007/978-3-319-30726-8_10
Bleeding Associated with Thrombocytopenia
S. Sartain (2016)
10.1182/asheducation-2015.1.237
Bleeding complications in immune thrombocytopenia.
D. Arnold (2015)
10.1111/jth.12813
Severe bleeding events in adults and children with primary immune thrombocytopenia: a systematic review
C. Neunert (2015)
10.1016/j.jpeds.2014.10.001
Newly diagnosed immune thrombocytopenic purpura in childhood: successful implementation of a limited intervention strategy in the setting of pediatric emergency care.
B. Rohmer (2015)
The psychological profile of children with immune thrombocytopenia and the factors influencing well-being
Sarah Towner (2015)
10.1097/MPH.0000000000000023
Health-related Quality of Life of Egyptian Children With Immune Thrombocytopenia and Their Parents
G. Mokhtar (2014)
UvA-DARE ( Digital Academic Repository ) Pediatric immune thrombocytopenia : Catching platelets
Laarhoven (2014)
10.3324/haematol.2014.106963
Health-related quality of life in children with newly diagnosed immune thrombocytopenia
K. M. Heitink-Pollé (2014)
10.1111/bjh.12889
A review of the management of childhood immune thrombocytopenia: how can we provide an evidence‐based approach?
N. Cooper (2014)
10.3109/08880018.2014.915443
ITP-QoL Questionnaire for Children with Immune Thrombocytopenia: Italian Version validation's
P. Giordano (2014)
10.1111/bjh.12124
The beta 1 tubulin R307H single nucleotide polymorphism is associated with treatment failures in immune thrombocytopenia (ITP)
P. Basciano (2013)
See more
Semantic Scholar Logo Some data provided by SemanticScholar